Skip to content

Clinical trials

Observational Polyradiculoneuropathy, Chronic Inflammatory Demyelinating trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Phase: Observational Country / region: United States Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20131
20151
20201
20212
20221
20232
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting5
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Takeda2
argenx2
Charles M Knudson1
Rutgers, The State University of New Jersey1
Sanguine Biosciences1
Sanofi1
State University of New York at Buffalo1
University of Minnesota1
Vanderbilt University Medical Center1
Zarife Sahenk1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating12
Acquired Immunodeficiency Syndrome1
Alopecia Areata1
Anemia, Sickle Cell1
Arthritis, Psoriatic1
Asthma1
Bipolar Disorder1
Breast Neoplasms1
Celiac Disease1
Charcot-Marie-Tooth Disease1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.